MIRA Pharmaceuticals, Inc.
MIRA
$0.9389
-$0.1311-12.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -31.65% | 46.77% | -19.98% | -23.33% | -21.57% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -36.84% | -20.26% | -41.39% | -24.00% | 20.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -31.75% | 44.29% | -21.04% | -23.55% | -19.98% |
|
|
|||||
| Total Current Assets | -31.75% | 44.29% | -21.04% | -23.55% | -19.98% |
| Net Property, Plant & Equipment | -- | -- | -- | -74.51% | -95.54% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -57.45% | -11.02% | 35.12% | -97.56% |
| Total Assets | -31.49% | 41.48% | -20.83% | -22.78% | -45.31% |
|
|
|||||
| Total Accounts Payable | 4.40% | -11.42% | 22.91% | 18.14% | -30.91% |
| Total Accrued Expenses | -- | -- | 0.00% | 0.00% | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -74.51% | -93.14% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.40% | -13.03% | 22.18% | 16.82% | -35.73% |
|
|
|||||
| Total Current Liabilities | 4.40% | -13.03% | 22.18% | 16.82% | -35.73% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.40% | -13.03% | 22.18% | 16.82% | -38.19% |
|
|
|||||
| Common Stock & APIC | 3.38% | 12.63% | 2.88% | 1.95% | 8.67% |
| Retained Earnings | -8.97% | -8.28% | -7.35% | -8.07% | -37.34% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -38.44% | 61.05% | -29.71% | -27.83% | -46.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.44% | 61.05% | -29.71% | -27.83% | -46.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.44% | 61.05% | -29.71% | -27.83% | -46.10% |
|
|
|||||